Vanda Pharmaceuticals | VNDA - PE Price to Earnings


Vanda Pharmaceuticals reported 16.79 in PE Price to Earnings for its fiscal quarter ending in June of 2023.





Pe Change Date
Acadia Pharmaceuticals USD 11.61 2.09 Dec/2025
Agios Pharmaceuticals USD 3.56 0.68 Sep/2025
Akebia Therapeutics 26.5 0.19 Sep/2023
Alnylam Pharmaceuticals 170.7 367.33 Dec/2025
Anika Therapeutics 47.54 27.2 Jun/2024
AstraZeneca USD 27.29 5.8 Dec/2025
Bristol-Myers Squibb USD 9.28 1.04 Dec/2025
Eli Lilly USD 40.21 9.66 Dec/2025
Esperion Therapeutics 129.79 129 Dec/2024
Halozyme Therapeutics USD 23.16 7.7 Dec/2025
J&J USD 23.62 0.86 Dec/2025
Lexicon Pharmaceuticals 12.44 4.73 Jun/2021
Ligand Pharmaceuticals USD 60.65 17.62 Sep/2025
Merck USD 13.92 5.08 Dec/2025
Moderna USD 27.22 14.51 Jun/2023
Novartis USD 16.05 2.92 Sep/2025
Pfizer USD 14.48 5.18 Dec/2025
PTC Therapeutics USD 9.98 3.25 Dec/2025
Puma Biotechnology 13.93 44.88 Jun/2024
Sanofi EUR 11.99 1.58 Dec/2025
Takeda JPY 235.05 184.95 Dec/2025
Teva Pharmaceutical Industries USD 10.11 1.04 Dec/2025
Vanda Pharmaceuticals 16.79 7.07 Jun/2023
Veracyte USD 45.3 5.4 Dec/2025